What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
Internal medicine, Acute lymphocytic leukemia, Thiopurine methyltransferase, Childhood Acute Lymphoblastic Leukemia and Immunology are his primary areas of study.
His Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Oncology.
His studies in Acute lymphocytic leukemia integrate themes in fields like Cytarabine, Methotrexate, Pediatrics and Asparaginase.
His Thiopurine methyltransferase research is multidisciplinary, relying on both Mercaptopurine, Pharmacology and Pharmacogenetics.
His Childhood Acute Lymphoblastic Leukemia research incorporates elements of Survival rate, Childhood all, Myelodysplastic syndromes and Risk factor.
His studies deal with areas such as Cancer research, Incidence, Cytogenetics, Single-nucleotide polymorphism and Polymerase chain reaction as well as Immunology.
His most cited work include:
- Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing. (422 citations)
- Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration (410 citations)
- Human thiopurine methyltransferase pharmacogenetics: Gene sequence polymorphisms (358 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Childhood Acute Lymphoblastic Leukemia, Pediatrics, Immunology and Gastroenterology.
As a member of one scientific family, Kjeld Schmiegelow mostly works in the field of Internal medicine, focusing on Oncology and, on occasion, Flow cytometry.
His Childhood Acute Lymphoblastic Leukemia research incorporates themes from Hematology, Pharmacokinetics, Surgery and Minimal residual disease.
His study in Pediatrics is interdisciplinary in nature, drawing from both Cancer, Incidence, Confidence interval, Cohort and Risk factor.
Kjeld Schmiegelow has included themes like Asparaginase and Pathology in his Gastroenterology study.
In his research, Genotype is intimately related to Thiopurine methyltransferase, which falls under the overarching field of Maintenance therapy.
He most often published in these fields:
- Internal medicine (57.33%)
- Childhood Acute Lymphoblastic Leukemia (33.95%)
- Pediatrics (27.27%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (57.33%)
- Childhood Acute Lymphoblastic Leukemia (33.95%)
- Gastroenterology (21.34%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Childhood Acute Lymphoblastic Leukemia, Gastroenterology, Cancer and Oncology.
His study in Cumulative incidence, Minimal residual disease, Asparaginase, Hazard ratio and Methotrexate falls under the purview of Internal medicine.
His Childhood Acute Lymphoblastic Leukemia research integrates issues from Area under the curve, Gerontology, Quality of life, Maintenance therapy and Psycho-oncology.
His Gastroenterology research is multidisciplinary, incorporating perspectives in Mucositis, Chemotherapy, Toxicity, Pharmacokinetics and Interquartile range.
His study focuses on the intersection of Cancer and fields such as Randomized controlled trial with connections in the field of Intervention.
The concepts of his Oncology study are interwoven with issues in Genome-wide association study, Single-nucleotide polymorphism, Meta-analysis, Disease and Flow cytometry.
Between 2018 and 2021, his most popular works were:
- Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update (147 citations)
- Flash survey on severe acute respiratory syndrome coronavirus-2 infections in paediatric patients on anticancer treatment. (70 citations)
- Association Between Fertility Treatment and Cancer Risk in Children. (30 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Gene
His scientific interests lie mostly in Internal medicine, Childhood Acute Lymphoblastic Leukemia, Hazard ratio, Gastroenterology and Minimal residual disease.
His is doing research in Chemotherapy, Asparaginase, Hematology, Proportional hazards model and Methotrexate, both of which are found in Internal medicine.
His work in Childhood Acute Lymphoblastic Leukemia addresses issues such as Odds ratio, which are connected to fields such as Posterior reversible encephalopathy syndrome and Leukemia.
His research integrates issues of Cancer registry, Medical prescription, Cumulative incidence and Pediatrics in his study of Hazard ratio.
His work carried out in the field of Cumulative incidence brings together such families of science as White blood cell, Immunophenotyping and Oncology.
While the research belongs to areas of Gastroenterology, he spends his time largely on the problem of Toxicity, intersecting his research to questions surrounding Immunology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
